vs
Side-by-side financial comparison of Acadia Healthcare Company, Inc. (ACHC) and NCR Voyix Corp (VYX). Click either name above to swap in a different company.
Acadia Healthcare Company, Inc. is the larger business by last-quarter revenue ($821.5M vs $720.0M, roughly 1.1× NCR Voyix Corp). NCR Voyix Corp runs the higher net margin — 13.6% vs -143.3%, a 157.0% gap on every dollar of revenue. On growth, NCR Voyix Corp posted the faster year-over-year revenue change (6.2% vs 6.1%). Over the past eight quarters, Acadia Healthcare Company, Inc.'s revenue compounded faster (3.4% CAGR vs 0.7%).
Acadia Healthcare Company, Inc. is an American provider of for-profit behavioral healthcare services. It operates a network of over 225 facilities across the United States and Puerto Rico.
NCR Voyix Corporation, previously known as NCR Corporation and National Cash Register, is a global software, consulting and technology company providing several professional services and electronic products. It manufactured self-service kiosks, point-of-sale terminals, automated teller machines, check processing systems, and barcode scanners.
ACHC vs VYX — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $821.5M | $720.0M |
| Net Profit | $-1.2B | $98.0M |
| Gross Margin | — | — |
| Operating Margin | -142.4% | 2.4% |
| Net Margin | -143.3% | 13.6% |
| Revenue YoY | 6.1% | 6.2% |
| Net Profit YoY | -3710.4% | 990.9% |
| EPS (diluted) | $-12.98 | $0.64 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $821.5M | $720.0M | ||
| Q3 25 | $851.6M | $684.0M | ||
| Q2 25 | $869.2M | $666.0M | ||
| Q1 25 | $770.5M | $617.0M | ||
| Q4 24 | $774.2M | $678.0M | ||
| Q3 24 | $815.6M | $708.0M | ||
| Q2 24 | $796.0M | $722.0M | ||
| Q1 24 | $768.1M | $710.0M |
| Q4 25 | $-1.2B | $98.0M | ||
| Q3 25 | $36.2M | $-19.0M | ||
| Q2 25 | $30.1M | $0 | ||
| Q1 25 | $8.4M | $-17.0M | ||
| Q4 24 | $32.6M | $-11.0M | ||
| Q3 24 | $68.1M | $1.1B | ||
| Q2 24 | $78.5M | $-73.0M | ||
| Q1 24 | $76.4M | $-40.0M |
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | 23.4% | ||
| Q2 24 | — | 17.5% | ||
| Q1 24 | — | 19.4% |
| Q4 25 | -142.4% | 2.4% | ||
| Q3 25 | 4.7% | 2.2% | ||
| Q2 25 | 5.8% | 2.1% | ||
| Q1 25 | 1.7% | -3.2% | ||
| Q4 24 | 4.9% | -0.1% | ||
| Q3 24 | 12.1% | 2.3% | ||
| Q2 24 | 13.4% | -4.7% | ||
| Q1 24 | 12.9% | -2.7% |
| Q4 25 | -143.3% | 13.6% | ||
| Q3 25 | 4.3% | -2.8% | ||
| Q2 25 | 3.5% | — | ||
| Q1 25 | 1.1% | -2.8% | ||
| Q4 24 | 4.2% | -1.6% | ||
| Q3 24 | 8.4% | 152.8% | ||
| Q2 24 | 9.9% | -10.1% | ||
| Q1 24 | 9.9% | -5.6% |
| Q4 25 | $-12.98 | $0.64 | ||
| Q3 25 | $0.40 | $-0.16 | ||
| Q2 25 | $0.33 | $-0.03 | ||
| Q1 25 | $0.09 | $-0.15 | ||
| Q4 24 | $0.36 | $-0.05 | ||
| Q3 24 | $0.74 | $7.41 | ||
| Q2 24 | $0.85 | $-0.53 | ||
| Q1 24 | $0.83 | $-0.31 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $133.2M | $231.0M |
| Total DebtLower is stronger | $2.5B | $1.1B |
| Stockholders' EquityBook value | $1.9B | $948.0M |
| Total Assets | $5.5B | $3.9B |
| Debt / EquityLower = less leverage | 1.28× | 1.17× |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $133.2M | $231.0M | ||
| Q3 25 | $118.7M | $282.0M | ||
| Q2 25 | $131.4M | $276.0M | ||
| Q1 25 | $91.2M | $573.0M | ||
| Q4 24 | $76.3M | $722.0M | ||
| Q3 24 | $82.1M | $792.0M | ||
| Q2 24 | $77.2M | $203.0M | ||
| Q1 24 | $77.3M | $241.0M |
| Q4 25 | $2.5B | $1.1B | ||
| Q3 25 | $2.3B | — | ||
| Q2 25 | $2.3B | — | ||
| Q1 25 | $2.2B | — | ||
| Q4 24 | $2.0B | $1.1B | ||
| Q3 24 | $1.9B | — | ||
| Q2 24 | $1.8B | — | ||
| Q1 24 | $1.9B | — |
| Q4 25 | $1.9B | $948.0M | ||
| Q3 25 | $3.1B | $848.0M | ||
| Q2 25 | $3.1B | $867.0M | ||
| Q1 25 | $3.0B | $857.0M | ||
| Q4 24 | $3.1B | $933.0M | ||
| Q3 24 | $3.0B | $1.0B | ||
| Q2 24 | $3.0B | $-85.0M | ||
| Q1 24 | $2.9B | $-34.0M |
| Q4 25 | $5.5B | $3.9B | ||
| Q3 25 | $6.4B | $4.0B | ||
| Q2 25 | $6.3B | $4.0B | ||
| Q1 25 | $6.1B | $4.3B | ||
| Q4 24 | $6.0B | $4.5B | ||
| Q3 24 | $5.9B | $4.7B | ||
| Q2 24 | $5.7B | $4.8B | ||
| Q1 24 | $5.5B | $5.0B |
| Q4 25 | 1.28× | 1.17× | ||
| Q3 25 | 0.74× | — | ||
| Q2 25 | 0.74× | — | ||
| Q1 25 | 0.72× | — | ||
| Q4 24 | 0.64× | 1.18× | ||
| Q3 24 | 0.62× | — | ||
| Q2 24 | 0.62× | — | ||
| Q1 24 | 0.65× | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $-86.3M | $60.0M |
| Free Cash FlowOCF − Capex | $-179.5M | — |
| FCF MarginFCF / Revenue | -21.8% | — |
| Capex IntensityCapex / Revenue | 11.3% | — |
| Cash ConversionOCF / Net Profit | — | 0.61× |
| TTM Free Cash FlowTrailing 4 quarters | $-439.9M | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $-86.3M | $60.0M | ||
| Q3 25 | $73.2M | $14.0M | ||
| Q2 25 | $133.5M | $-242.0M | ||
| Q1 25 | $11.5M | $-42.0M | ||
| Q4 24 | $116.7M | $-170.0M | ||
| Q3 24 | $163.1M | $11.0M | ||
| Q2 24 | $171.1M | $62.0M | ||
| Q1 24 | $-321.3M | $-35.0M |
| Q4 25 | $-179.5M | — | ||
| Q3 25 | $-63.0M | $10.0M | ||
| Q2 25 | $-34.2M | $-249.0M | ||
| Q1 25 | $-163.2M | $-50.0M | ||
| Q4 24 | $-86.8M | $-177.0M | ||
| Q3 24 | $-27.1M | $9.0M | ||
| Q2 24 | $16.9M | $49.0M | ||
| Q1 24 | $-463.7M | $-43.0M |
| Q4 25 | -21.8% | — | ||
| Q3 25 | -7.4% | 1.5% | ||
| Q2 25 | -3.9% | -37.4% | ||
| Q1 25 | -21.2% | -8.1% | ||
| Q4 24 | -11.2% | -26.1% | ||
| Q3 24 | -3.3% | 1.3% | ||
| Q2 24 | 2.1% | 6.8% | ||
| Q1 24 | -60.4% | -6.1% |
| Q4 25 | 11.3% | — | ||
| Q3 25 | 16.0% | 0.6% | ||
| Q2 25 | 19.3% | 1.1% | ||
| Q1 25 | 22.7% | 1.3% | ||
| Q4 24 | 26.3% | 1.0% | ||
| Q3 24 | 23.3% | 0.3% | ||
| Q2 24 | 19.4% | 1.8% | ||
| Q1 24 | 18.5% | 1.1% |
| Q4 25 | — | 0.61× | ||
| Q3 25 | 2.02× | — | ||
| Q2 25 | 4.43× | — | ||
| Q1 25 | 1.37× | — | ||
| Q4 24 | 3.58× | — | ||
| Q3 24 | 2.39× | 0.01× | ||
| Q2 24 | 2.18× | — | ||
| Q1 24 | -4.21× | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
ACHC
| Acute Inpatient Psychiatric Facilities | $451.2M | 55% |
| Comprehensive Treatment Centers | $144.2M | 18% |
| Medicare | $113.7M | 14% |
| Residential Treatment Centers | $89.7M | 11% |
| Self Payor | $16.1M | 2% |
| Other Payor | $10.7M | 1% |
VYX
| Services | $484.0M | 67% |
| Products | $236.0M | 33% |
